Nektar Therapeutics (NKTR)
(Delayed Data from NSDQ)
$1.32 USD
-0.06 (-4.35%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $1.32 0.00 (0.00%) 4:44 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/14/24 |
---|---|
Current Quarter | -0.20 |
EPS Last Quarter | -0.22 |
Last EPS Surprise | -10.00% |
ABR | 3.50 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.98 |
Next Year | -0.68 |
EPS (TTM) | -0.93 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 16.98M | 17.10M | 72.14M | 65.63M |
# of Estimates | 4 | 4 | 5 | 5 |
High Estimate | 23.17M | 23.17M | 92.67M | 92.67M |
Low Estimate | 5.40M | 5.40M | 22.20M | 22.90M |
Year ago Sales | 21.59M | 20.50M | 90.12M | 72.14M |
Year over Year Growth Est. | -21.37% | -16.61% | -19.96% | -9.02% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.20 | -0.20 | -0.98 | -0.68 |
# of Estimates | 4 | 4 | 4 | 4 |
Most Recent Consensus | -0.22 | -0.21 | -0.93 | -0.91 |
High Estimate | -0.18 | -0.18 | -0.77 | -0.31 |
Low Estimate | -0.22 | -0.22 | -1.32 | -1.00 |
Year ago EPS | -0.25 | -0.27 | -1.45 | -0.98 |
Year over Year Growth Est. | 20.00% | 25.93% | 32.41% | 30.87% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 0 | 0 | 2 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 2 | 2 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.20 | -0.20 | -0.98 | -0.68 |
7 Days Ago | -0.20 | -0.20 | -0.98 | -0.68 |
30 Days Ago | -0.20 | -0.20 | -0.98 | -0.69 |
60 Days Ago | -0.18 | -0.16 | -0.91 | -0.51 |
90 Days Ago | -0.18 | -0.17 | -0.81 | -0.49 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.20 | -0.20 | -0.98 | -0.91 |
Zacks Consensus Estimate | -0.20 | -0.20 | -0.98 | -0.68 |
Earnings ESP | 0.00% | 0.00% | 0.00% | -33.82% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.22 | -0.19 | -0.27 | -0.25 | NA |
Estimate | -0.20 | -0.18 | -0.30 | -0.26 | NA |
Difference | -0.02 | -0.01 | 0.03 | 0.01 | 0.00 |
Surprise | -10.00% | -5.56% | 10.00% | 3.85% | -0.43% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more